Thrombopoietin acts synergistically with LIF to maintain an undifferentiated state of embryonic stem cells homozygous for a Shp-2 deletion mutation

FEBS Lett. 2002 Oct 9;529(2-3):361-4. doi: 10.1016/s0014-5793(02)03400-2.

Abstract

Thrombopoietin (Tpo) and its receptor, c-mpl, are expressed in murine embryonic stem (ES) cells. ES cells are maintained in a pluripotent state by leukemia inhibitory factor (LIF) via activation of the Janus kinase (Jak)-STAT3 signaling pathway. Tpo, like LIF, activates STAT3. We report that Tpo increases the number of undifferentiated colonies derived from wild type or Shp-2 mutant (Shp-2(Delta46-110)) ES cells. Tpo plus LIF acted synergistically on the Shp-2(Delta46-110) ES cells to maintain undifferentiated colonies but no evidence of synergism via Jak-STAT3 activation was detected. Collectively, these data suggest that Tpo can play a role in preventing ES cell differentiation via Jak-STAT3 activation and perhaps via novel pathways that are enhanced in the absence of functional Shp-2.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Differentiation
  • Cells, Cultured
  • DNA-Binding Proteins / physiology
  • Embryo, Mammalian / cytology
  • Embryo, Nonmammalian
  • Growth Inhibitors / physiology*
  • Homozygote*
  • Interleukin-6*
  • Intracellular Signaling Peptides and Proteins
  • Leukemia Inhibitory Factor
  • Lymphokines / physiology*
  • Mutation*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases / genetics*
  • STAT3 Transcription Factor
  • Sequence Deletion*
  • Stem Cells / cytology*
  • Thrombopoietin / physiology*
  • Trans-Activators / physiology

Substances

  • DNA-Binding Proteins
  • Growth Inhibitors
  • Interleukin-6
  • Intracellular Signaling Peptides and Proteins
  • Leukemia Inhibitory Factor
  • Lymphokines
  • STAT3 Transcription Factor
  • Trans-Activators
  • Thrombopoietin
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases